Inventor · Montclair, NJ, US

Daniel Hicklin

26Patents
8h-index
35Co-inventors
75Inventor score

Filing activity: Jun 6, 1994 → Feb 9, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US9605070B2 Antibody molecules to TIM-3 and uses thereof Emerging Cross-Sectional Technologies 50 Active
US9713641B2 Anti-TIGIT antigen-binding proteins and methods of use thereof Emerging Cross-Sectional Technologies 26 Active
US10232053B2 Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer Chemistry; Metallurgy 18 Active
US10696723B2 Activatable interleukin 12 polypeptides Chemistry; Metallurgy 11 Active
US10696724B2 Activatable interleukin-2 polypeptides Chemistry; Metallurgy 11 Active
US10472419B2 Antibody molecules to TIM-3 and uses thereof Emerging Cross-Sectional Technologies 11 Active
US9884913B2 Antibody molecules to TIM-3 and uses thereof Emerging Cross-Sectional Technologies 11 Active
US10981990B2 Antibody molecules to TIM-3 and uses thereof Emerging Cross-Sectional Technologies 10 Active
US11155620B2 Method of detecting TIM-3 using antibody molecules to TIM-3 Emerging Cross-Sectional Technologies 5 Active
US10507244B2 Anti-TIGIT antigen-binding proteins and methods of use thereof Emerging Cross-Sectional Technologies 3 Active
US11352403B2 Activatable interleukin-2 polypeptides and methods of use thereof Chemistry; Metallurgy 2 Active
US7371574B2 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability Chemistry; Metallurgy 1 Expired
US10227413B2 Anti-neuropilin antigen-binding proteins and methods of use thereof Emerging Cross-Sectional Technologies 1 Active
US8143025B2 Antibodies against vascular endothelial growth factor receptor-1 Chemistry; Metallurgy 1 Active
US5501948A Stabilized hepatitis B e antigen suitable for immunoassays Emerging Cross-Sectional Technologies 1 Expired
US11590224B2 Anti-TIGIT antigen-binding proteins and methods of uses thereof Emerging Cross-Sectional Technologies 0 Active
US12275769B2 Activatable interleukin 12 polypeptides and methods of use thereof Chemistry; Metallurgy 0 Active
US11739132B2 Separation moieties and methods of use thereof Chemistry; Metallurgy 0 Active
US10988545B2 Anti-GITR antigen-binding proteins and methods of use thereof Chemistry; Metallurgy 0 Active
US11453720B2 Anti-TIGIT antigen-binding proteins and methods of use thereof Emerging Cross-Sectional Technologies 0 Active
US11186644B2 Anti-neuropilin antigen-binding proteins and methods of use thereof Emerging Cross-Sectional Technologies 0 Active
US11535658B2 Activatable interleukin-2 polypeptides and methods of use thereof Chemistry; Metallurgy 0 Active
US11453710B2 Activatable interleukin 12 polypeptides and methods of use thereof Chemistry; Metallurgy 0 Active
US12036266B2 Activatable cytokine polypeptides and methods of use thereof Chemistry; Metallurgy 0 Active
US12076371B2 Activatable cytokine polypeptides and methods of use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.